Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model

被引:43
作者
Kipshidze, NN
Kim, HS
Iversen, P
Yazdi, HA
Bhargava, B
New, G
Mehran, R
Tio, F
Haudenschild, C
Dangas, G
Stone, G
Iyer, S
Roubin, GS
Leon, MB
Moses, JW
机构
[1] Lenox Hill Heart & Vasc Inst, New York, NY 10021 USA
[2] Cardiovasc Res Fdn, New York, NY USA
[3] Cardiovasc Res Inst, Washington, DC USA
[4] AVI BioPharma, Portland, OR USA
[5] Biomed Res Fdn S Texas, San Antonio, TX USA
[6] Amer Red Cross, Jerome Holland Labs, Rockville, MD USA
关键词
D O I
10.1016/S0735-1097(02)01830-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We evaluated the long-term influence of intramural delivery of advanced c-myc neutrally charged antisense oligonucleotides (Resten-NG) on neointimal hyperplasia after stenting in a pig model. BACKGROUND Neointimal hyperplasia after percutaneous coronary interventions is one of the key components of the restenotic process. The c-myc is a critical cell division cycle protein involved in the formation of neointima. METHODS In short-term experiments, different doses (from 500 mug to 5 mg) of Resten-NG or saline were delivered to the stent implantation site with an infiltrator delivery system (Interventional Technologies, San Diego, California). Animals were euthanized at 2, 6 and 18 h after interventions, and excised vessels were analyzed for c-myc expression by Western blot. In long-term experiments, either saline or a dose of 1, 5 or 10 mg of Resten-NG was delivered in the same fashion, and animals were euthanized at 28 days after the intervention. RESULTS Western blot analysis demonstrated inhibition of c-myc expression and was dose dependent. Morphometry showed that the intimal area was 3.88 +/- 1.04 mm(2) in the control. There was statistically significant reduction of intimal areas in the 5 and 10 mg groups (2.01 +/- 0.66 and 1.95 +/- 0.91, respectively, p < 0.001) but no significant reduction in the 1 mg group (2.81 +/- 0.56, p > 0.5) in comparison with control. CONCLUSIONS This study demonstrated that intramural delivery, of advanced c-myc neutrally charged antisense morpholino compound completely inhibits c-myc expression and dramatically reduces neointimal formation in a dose dependent fashion in a porcine coronary stent restenosis model, while allowing for complete vascular healing. (J Am Coll Cardiol 2002; 39:1686-91) (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:1686 / 1691
页数:6
相关论文
共 31 条
[1]   C-MYC IN VASCULOPROLIFERATIVE DISEASE [J].
EDELMAN, ER ;
SIMONS, M ;
SIROIS, MG ;
ROSENBERG, RD .
CIRCULATION RESEARCH, 1995, 76 (02) :176-182
[2]   Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy [J].
Ehsan, A ;
Mann, MJ ;
Dell'Acqua, G ;
Dzau, VJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (04) :714-722
[3]   Pathological analysis of local delivery of paclitaxel via a polymer-coated stent [J].
Farb, A ;
Heller, PF ;
Shroff, S ;
Cheng, L ;
Kolodgie, FD ;
Carter, AJ ;
Scott, DS ;
Froehlich, J ;
Virmani, R .
CIRCULATION, 2001, 104 (04) :473-479
[4]   The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty [J].
Gunn, J ;
Holt, CM ;
Francis, SE ;
Shepherd, L ;
Grohmann, M ;
Newman, CMH ;
Crossman, DC ;
Cumberland, DC .
CIRCULATION RESEARCH, 1997, 80 (04) :520-531
[5]   Local paclitaxel delivery for the prevention of restenosis:: Biological effects and efficacy in vivo [J].
Herdeg, C ;
Oberhoff, M ;
Baumbach, A ;
Blattner, A ;
Axel, DI ;
Schröder, S ;
Heinle, H ;
Karsch, KR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (07) :1969-1976
[6]   Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation [J].
Hudziak, RM ;
Barofsky, E ;
Barofsky, DF ;
Weller, DL ;
Huang, SB ;
Weller, DD .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (04) :267-272
[7]   Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury model [J].
Kipshidze, N ;
Keane, E ;
Stein, D ;
Chawla, P ;
Skrinska, V ;
Shankar, LR ;
Khanna, A ;
Komorowski, R ;
Haudenschild, C ;
Iversen, P ;
Leon, MB ;
Keelan, MH ;
Moses, J .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 54 (02) :247-256
[8]   In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia [J].
Kornowski, R ;
Hong, MK ;
Tio, FO ;
Bramwell, O ;
Wu, HS ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (01) :224-230
[9]   Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis - Results of the randomized investigation by the thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial [J].
Kutryk, MJB ;
Foley, DP ;
van den Brand, M ;
Hamburger, JN ;
van der Giessen, WJ ;
deFeyter, PJ ;
Bruining, N ;
Sabate, M ;
Serruys, PW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :281-287
[10]   RNASE-H IS RESPONSIBLE FOR THE NONSPECIFIC INHIBITION OF IN-VITRO TRANSLATION BY 2'-O-ALKYL CHIMERIC OLIGONUCLEOTIDES - HIGH-AFFINITY OR SELECTIVITY, A DILEMMA TO DESIGN ANTISENSE OLIGOMERS [J].
LARROUY, B ;
BOIZIAU, C ;
SPROAT, B ;
TOULME, JJ .
NUCLEIC ACIDS RESEARCH, 1995, 23 (17) :3434-3440